Novo Integrated Sciences, Inc.

About Novo Integrated Sciences, Inc.

Novo Integrated Sciences is a U.S.-based parent company, publicly traded on the OTC Markets Group (OTC:NVOS), focused on advancing patient-centric care through rehabilitative science, advanced therapeutics, and medical technology. Their mission is to decentralize healthcare delivery through innovations in medical technology and interconnectivity, aiming to transform healthcare fundamentally.

Products & Services

Healthcare:Multidisciplinary primary care services provided through various settings including in-clinic, long-term care, and retirement homes, focusing on high-quality service and unique care delivery.

Medical Technology:Development and availability of technology-driven care delivery methods to improve quality of life by expanding access to medical equipment and patient interface communications.

Research & Development:Focused on oncology research, diagnostics, and therapeutics to advance medical solutions.

Manufacturing:Production of nutraceuticals, over-the-counter supplements, and functional foods.

Wellness:Services focused on prevention and wellbeing to support overall health.

Specialties

Rehabilitative Science Advanced Therapeutics Medical Technology Decentralized Healthcare Delivery Oncology Research Diagnostics Nutraceuticals Multidisciplinary Primary Care

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: SBLC Monetization T: - FT: SBLC Monetization	A: 78000000 MR: - FA: approximately $78 million FAN: 78000000	D: 2024-07-18 FD: 2024-07-18	-
2	RT: SBLC Monetizing Program T: - FT: SBLC Monetizing Program	A: 78000000 MR: - FA: approximately $78 million FAN: 78000000	D: 2024-06-13 FD: 2024-06-13	1 investors
3	RT: Debt T: - FT: Debt	A: 70000000 MR: - FA: $70,000,000 FAN: 70000000	D: 2024-06-03 FD: 2024-06-03	1 investors
4	RT: Debt T: - FT: Debt	A: 78000000 MR: - FA: approximately $78 million FAN: 78000000	D: 2024-05-30 FD: 2024-05-30	-
5	RT: Debt T: - FT: Debt	A: 6210000 MR: - FA: $6,210,000 FAN: 6210000	D: 2024-04-08 FD: 2024-04-08	1 investors
6	RT: Debt T: - FT: Debt	A: 70000000 MR: - FA: $70,000,000 FAN: 70000000	D: 2024-02-20 FD: 2024-02-20	1 investors
7	RT: Debt T: - FT: Debt	A: 1000000000 MR: - FA: $1 Billion FAN: 1000000000	D: 2023-12-19 FD: 2023-12-19	1 investors
8	RT: Debt T: - FT: Debt	A: 70000000 MR: - FA: $70,000,000 FAN: 70000000	D: 2023-11-06 FD: 2023-11-06	1 investors
9	RT: Bond T: - FT: Bond	A: 1000000000 MR: - FA: One Billion Dollars FAN: 1000000000	D: 2023-11-03 FD: 2023-11-03	-
10	RT: Direct Investment T: - FT: Direct Investment	A: 40000000 MR: - FA: 40,000,000 FAN: 40000000	D: 2023-06-06 FD: 2023-06-06	1 investors
11	RT: Debt T: - FT: Debt	A: 57000000 MR: - FA: $57,000,000 FAN: 57000000	D: 2023-04-27 FD: 2023-04-27	1 investors

SBLC Monetization Latest

2024-07-18

$78.0M

SBLC Monetizing Program 2024-06-13

$78.0M

Debt 2024-06-03

$70.0M

View 10 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Robert Mattacchione

Board Chairman & CEO

LinkedIn (Pro only)

C

Chris David

Chief Operating Officer

LinkedIn (Pro only)

S

Sarfaraz Ali

Chairman, Compensation Committee, Audit Committee, Board of Directors

A

Alex Flesias

Chairman, Nominating & Corporate Governance Committee

V

Vivek Sethi

NVOS Principal Financial Officer (PFO)

View 2 more team members with Pro

Unlock Full Team Directory

Recent News